Deutsche Bank AG Purchases 316,918 Shares of Progyny, Inc. (NASDAQ:PGNY)

Deutsche Bank AG lifted its holdings in shares of Progyny, Inc. (NASDAQ:PGNY - Free Report) by 533.2% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 376,357 shares of the company's stock after purchasing an additional 316,918 shares during the period. Deutsche Bank AG owned 0.44% of Progyny worth $6,492,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the business. Corton Capital Inc. bought a new position in Progyny in the fourth quarter valued at about $264,000. Brevan Howard Capital Management LP bought a new position in Progyny in the fourth quarter valued at about $904,000. Bastion Asset Management Inc. bought a new position in Progyny in the fourth quarter valued at about $850,000. Bank of America Corp DE boosted its holdings in Progyny by 3.7% in the fourth quarter. Bank of America Corp DE now owns 952,777 shares of the company's stock valued at $16,435,000 after acquiring an additional 33,668 shares during the last quarter. Finally, BNP Paribas Financial Markets bought a new position in Progyny in the fourth quarter valued at about $10,557,000. Institutional investors own 94.93% of the company's stock.

Analyst Ratings Changes

PGNY has been the topic of several recent research reports. JPMorgan Chase & Co. raised their price target on Progyny from $17.00 to $23.00 and gave the company a "neutral" rating in a report on Tuesday, January 28th. Bank of America raised their target price on Progyny from $21.00 to $25.00 and gave the stock a "buy" rating in a report on Tuesday, February 11th. Canaccord Genuity Group reduced their target price on Progyny from $23.00 to $21.00 and set a "hold" rating on the stock in a report on Monday, May 12th. Finally, BTIG Research upgraded Progyny from a "neutral" rating to a "buy" rating and set a $28.00 target price on the stock in a report on Monday, March 31st. Seven investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, Progyny presently has an average rating of "Hold" and an average price target of $23.45.

Progyny Trading Down 1.8%

Shares of NASDAQ:PGNY traded down $0.37 during trading on Friday, hitting $20.52. 822,500 shares of the company's stock traded hands, compared to its average volume of 1,710,099. The company has a market cap of $1.76 billion, a price-to-earnings ratio of 35.38, a price-to-earnings-growth ratio of 2.39 and a beta of 1.37. Progyny, Inc. has a 52 week low of $13.39 and a 52 week high of $30.42. The company has a 50-day moving average price of $22.15 and a 200-day moving average price of $19.93.

Progyny (NASDAQ:PGNY - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.45 by ($0.28). Progyny had a net margin of 5.03% and a return on equity of 11.36%. The firm had revenue of $324.04 million during the quarter, compared to analyst estimates of $307.86 million. During the same period in the prior year, the business posted $0.17 EPS. The firm's quarterly revenue was up 16.5% compared to the same quarter last year. On average, analysts predict that Progyny, Inc. will post 0.6 earnings per share for the current fiscal year.

Progyny Company Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.